Full Title CROSSCHECK-001: A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-250 in Participants with Relapsed or Refractory Acute Myeloid ...
Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback